Industry Research Reports
Home > Reports > Medical Devices & Consumables > Nuclear Radiopharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nuclear Radiopharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Industry: Medical Devices & Consumables
Published Date: 2024-01-04
Pages: 114 Pages
Report ld: 2435582
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
By Company
- Nihon Medi-Physics Co.,Ltd.
- Curium Pharma
- Cardinal Health
- Bayer Global
- GE Healthcare
- Mallinckrodt Pharmaceuticals
- Bracco Group
- Advanced Molecular-imaging Solution
- China Isotope & Radiation
- Ciaeriar
- Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Diagnostic
- Therapeutic
Segment by Application
- Oncology
- Thyroid
- Cardiology
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Nuclear Radiopharmaceutical, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nuclear Radiopharmaceutical by region & country, by Type, and by Application.
The Nuclear Radiopharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Radiopharmaceutical.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nuclear Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nuclear Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nuclear Radiopharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Nuclear Radiopharmaceutical Product Introduction
1.2 Global Nuclear Radiopharmaceutical Market Size Forecast
1.2.1 Global Nuclear Radiopharmaceutical Sales Value (2019-2030)
1.2.2 Global Nuclear Radiopharmaceutical Sales Volume (2019-2030)
1.2.3 Global Nuclear Radiopharmaceutical Sales Price (2019-2030)
1.3 Nuclear Radiopharmaceutical Market Trends & Drivers
1.3.1 Nuclear Radiopharmaceutical Industry Trends
1.3.2 Nuclear Radiopharmaceutical Market Drivers & Opportunity
1.3.3 Nuclear Radiopharmaceutical Market Challenges
1.3.4 Nuclear Radiopharmaceutical Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nuclear Radiopharmaceutical Players Revenue Ranking (2023)
2.2 Global Nuclear Radiopharmaceutical Revenue by Company (2019-2024)
2.3 Global Nuclear Radiopharmaceutical Players Sales Volume Ranking (2023)
2.4 Global Nuclear Radiopharmaceutical Sales Volume by Company Players (2019-2024)
2.5 Global Nuclear Radiopharmaceutical Average Price by Company (2019-2024)
2.6 Key Manufacturers Nuclear Radiopharmaceutical Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nuclear Radiopharmaceutical Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nuclear Radiopharmaceutical
2.9 Nuclear Radiopharmaceutical Market Competitive Analysis
2.9.1 Nuclear Radiopharmaceutical Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nuclear Radiopharmaceutical Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiopharmaceutical as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diagnostic
3.1.2 Therapeutic
3.2 Global Nuclear Radiopharmaceutical Sales Value by Type
3.2.1 Global Nuclear Radiopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nuclear Radiopharmaceutical Sales Value, by Type (2019-2030)
3.2.3 Global Nuclear Radiopharmaceutical Sales Value, by Type (%) (2019-2030)
3.3 Global Nuclear Radiopharmaceutical Sales Volume by Type
3.3.1 Global Nuclear Radiopharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nuclear Radiopharmaceutical Sales Volume, by Type (2019-2030)
3.3.3 Global Nuclear Radiopharmaceutical Sales Volume, by Type (%) (2019-2030)
3.4 Global Nuclear Radiopharmaceutical Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Thyroid
4.1.3 Cardiology
4.1.4 Others
4.2 Global Nuclear Radiopharmaceutical Sales Value by Application
4.2.1 Global Nuclear Radiopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nuclear Radiopharmaceutical Sales Value, by Application (2019-2030)
4.2.3 Global Nuclear Radiopharmaceutical Sales Value, by Application (%) (2019-2030)
4.3 Global Nuclear Radiopharmaceutical Sales Volume by Application
4.3.1 Global Nuclear Radiopharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nuclear Radiopharmaceutical Sales Volume, by Application (2019-2030)
4.3.3 Global Nuclear Radiopharmaceutical Sales Volume, by Application (%) (2019-2030)
4.4 Global Nuclear Radiopharmaceutical Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nuclear Radiopharmaceutical Sales Value by Region
5.1.1 Global Nuclear Radiopharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nuclear Radiopharmaceutical Sales Value by Region (2019-2024)
5.1.3 Global Nuclear Radiopharmaceutical Sales Value by Region (2025-2030)
5.1.4 Global Nuclear Radiopharmaceutical Sales Value by Region (%), (2019-2030)
5.2 Global Nuclear Radiopharmaceutical Sales Volume by Region
5.2.1 Global Nuclear Radiopharmaceutical Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nuclear Radiopharmaceutical Sales Volume by Region (2019-2024)
5.2.3 Global Nuclear Radiopharmaceutical Sales Volume by Region (2025-2030)
5.2.4 Global Nuclear Radiopharmaceutical Sales Volume by Region (%), (2019-2030)
5.3 Global Nuclear Radiopharmaceutical Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nuclear Radiopharmaceutical Sales Value, 2019-2030
5.4.2 North America Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nuclear Radiopharmaceutical Sales Value, 2019-2030
5.5.2 Europe Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nuclear Radiopharmaceutical Sales Value, 2019-2030
5.6.2 Asia Pacific Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nuclear Radiopharmaceutical Sales Value, 2019-2030
5.7.2 South America Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nuclear Radiopharmaceutical Sales Value, 2019-2030
5.8.2 Middle East & Africa Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nuclear Radiopharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nuclear Radiopharmaceutical Sales Value
6.2.1 Key Countries/Regions Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nuclear Radiopharmaceutical Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.3.2 United States Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nuclear Radiopharmaceutical Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.4.2 Europe Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nuclear Radiopharmaceutical Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.5.2 China Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nuclear Radiopharmaceutical Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.6.2 Japan Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nuclear Radiopharmaceutical Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.7.2 South Korea Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nuclear Radiopharmaceutical Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.8.2 Southeast Asia Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nuclear Radiopharmaceutical Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nuclear Radiopharmaceutical Sales Value, 2019-2030
6.9.2 India Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nuclear Radiopharmaceutical Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Nihon Medi-Physics Co.,Ltd.
7.1.1 Nihon Medi-Physics Co.,Ltd. Company Information
7.1.2 Nihon Medi-Physics Co.,Ltd. Introduction and Business Overview
7.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
7.1.5 Nihon Medi-Physics Co.,Ltd. Recent Development
7.2 Curium Pharma
7.2.1 Curium Pharma Company Information
7.2.2 Curium Pharma Introduction and Business Overview
7.2.3 Curium Pharma Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Curium Pharma Nuclear Radiopharmaceutical Product Offerings
7.2.5 Curium Pharma Recent Development
7.3 Cardinal Health
7.3.1 Cardinal Health Company Information
7.3.2 Cardinal Health Introduction and Business Overview
7.3.3 Cardinal Health Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cardinal Health Nuclear Radiopharmaceutical Product Offerings
7.3.5 Cardinal Health Recent Development
7.4 Bayer Global
7.4.1 Bayer Global Company Information
7.4.2 Bayer Global Introduction and Business Overview
7.4.3 Bayer Global Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bayer Global Nuclear Radiopharmaceutical Product Offerings
7.4.5 Bayer Global Recent Development
7.5 GE Healthcare
7.5.1 GE Healthcare Company Information
7.5.2 GE Healthcare Introduction and Business Overview
7.5.3 GE Healthcare Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GE Healthcare Nuclear Radiopharmaceutical Product Offerings
7.5.5 GE Healthcare Recent Development
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Company Information
7.6.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
7.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product Offerings
7.6.5 Mallinckrodt Pharmaceuticals Recent Development
7.7 Bracco Group
7.7.1 Bracco Group Company Information
7.7.2 Bracco Group Introduction and Business Overview
7.7.3 Bracco Group Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Bracco Group Nuclear Radiopharmaceutical Product Offerings
7.7.5 Bracco Group Recent Development
7.8 Advanced Molecular-imaging Solution
7.8.1 Advanced Molecular-imaging Solution Company Information
7.8.2 Advanced Molecular-imaging Solution Introduction and Business Overview
7.8.3 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product Offerings
7.8.5 Advanced Molecular-imaging Solution Recent Development
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Company Information
7.9.2 China Isotope & Radiation Introduction and Business Overview
7.9.3 China Isotope & Radiation Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.9.4 China Isotope & Radiation Nuclear Radiopharmaceutical Product Offerings
7.9.5 China Isotope & Radiation Recent Development
7.10 Ciaeriar
7.10.1 Ciaeriar Company Information
7.10.2 Ciaeriar Introduction and Business Overview
7.10.3 Ciaeriar Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Ciaeriar Nuclear Radiopharmaceutical Product Offerings
7.10.5 Ciaeriar Recent Development
7.11 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
7.11.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
7.11.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Introduction and Business Overview
7.11.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
7.11.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Development
8 Industry Chain Analysis
8.1 Nuclear Radiopharmaceutical Industrial Chain
8.2 Nuclear Radiopharmaceutical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nuclear Radiopharmaceutical Sales Model
8.5.2 Sales Channel
8.5.3 Nuclear Radiopharmaceutical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Nuclear Radiopharmaceutical Market Trends
Table 2. Nuclear Radiopharmaceutical Market Drivers & Opportunity
Table 3. Nuclear Radiopharmaceutical Market Challenges
Table 4. Nuclear Radiopharmaceutical Market Restraints
Table 5. Global Nuclear Radiopharmaceutical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nuclear Radiopharmaceutical Revenue Market Share by Company (2019-2024)
Table 7. Global Nuclear Radiopharmaceutical Sales Volume by Company (2019-2024) & (Units)
Table 8. Global Nuclear Radiopharmaceutical Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Nuclear Radiopharmaceutical Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Nuclear Radiopharmaceutical Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Nuclear Radiopharmaceutical Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Nuclear Radiopharmaceutical
Table 13. Global Nuclear Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiopharmaceutical as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Nuclear Radiopharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Nuclear Radiopharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Nuclear Radiopharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Nuclear Radiopharmaceutical Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
Table 22. Global Nuclear Radiopharmaceutical Sales Volume by Type (2019-2024) & (Units)
Table 23. Global Nuclear Radiopharmaceutical Sales Volume by Type (2025-2030) & (Units)
Table 24. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Nuclear Radiopharmaceutical Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Nuclear Radiopharmaceutical Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Nuclear Radiopharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Nuclear Radiopharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Nuclear Radiopharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Nuclear Radiopharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Nuclear Radiopharmaceutical Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
Table 34. Global Nuclear Radiopharmaceutical Sales Volume by Application (2019-2024) & (Units)
Table 35. Global Nuclear Radiopharmaceutical Sales Volume by Application (2025-2030) & (Units)
Table 36. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Nuclear Radiopharmaceutical Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Nuclear Radiopharmaceutical Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Nuclear Radiopharmaceutical Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Nuclear Radiopharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Nuclear Radiopharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Nuclear Radiopharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Nuclear Radiopharmaceutical Sales Value by Region (2019-2024) & (%)
Table 44. Global Nuclear Radiopharmaceutical Sales Value by Region (2025-2030) & (%)
Table 45. Global Nuclear Radiopharmaceutical Sales Volume by Region (Units): 2019 VS 2023 VS 2030
Table 46. Global Nuclear Radiopharmaceutical Sales Volume by Region (2019-2024) & (Units)
Table 47. Global Nuclear Radiopharmaceutical Sales Volume by Region (2025-2030) & (Units)
Table 48. Global Nuclear Radiopharmaceutical Sales Volume by Region (2019-2024) & (%)
Table 49. Global Nuclear Radiopharmaceutical Sales Volume by Region (2025-2030) & (%)
Table 50. Global Nuclear Radiopharmaceutical Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Nuclear Radiopharmaceutical Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Nuclear Radiopharmaceutical Sales Volume, (2019-2024) & (Units)
Table 56. Key Countries/Regions Nuclear Radiopharmaceutical Sales Volume, (2025-2030) & (Units)
Table 57. Nihon Medi-Physics Co.,Ltd. Company Information
Table 58. Nihon Medi-Physics Co.,Ltd. Introduction and Business Overview
Table 59. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
Table 61. Nihon Medi-Physics Co.,Ltd. Recent Development
Table 62. Curium Pharma Company Information
Table 63. Curium Pharma Introduction and Business Overview
Table 64. Curium Pharma Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Curium Pharma Nuclear Radiopharmaceutical Product Offerings
Table 66. Curium Pharma Recent Development
Table 67. Cardinal Health Company Information
Table 68. Cardinal Health Introduction and Business Overview
Table 69. Cardinal Health Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Cardinal Health Nuclear Radiopharmaceutical Product Offerings
Table 71. Cardinal Health Recent Development
Table 72. Bayer Global Company Information
Table 73. Bayer Global Introduction and Business Overview
Table 74. Bayer Global Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Bayer Global Nuclear Radiopharmaceutical Product Offerings
Table 76. Bayer Global Recent Development
Table 77. GE Healthcare Company Information
Table 78. GE Healthcare Introduction and Business Overview
Table 79. GE Healthcare Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. GE Healthcare Nuclear Radiopharmaceutical Product Offerings
Table 81. GE Healthcare Recent Development
Table 82. Mallinckrodt Pharmaceuticals Company Information
Table 83. Mallinckrodt Pharmaceuticals Introduction and Business Overview
Table 84. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product Offerings
Table 86. Mallinckrodt Pharmaceuticals Recent Development
Table 87. Bracco Group Company Information
Table 88. Bracco Group Introduction and Business Overview
Table 89. Bracco Group Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Bracco Group Nuclear Radiopharmaceutical Product Offerings
Table 91. Bracco Group Recent Development
Table 92. Advanced Molecular-imaging Solution Company Information
Table 93. Advanced Molecular-imaging Solution Introduction and Business Overview
Table 94. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product Offerings
Table 96. Advanced Molecular-imaging Solution Recent Development
Table 97. China Isotope & Radiation Company Information
Table 98. China Isotope & Radiation Introduction and Business Overview
Table 99. China Isotope & Radiation Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. China Isotope & Radiation Nuclear Radiopharmaceutical Product Offerings
Table 101. China Isotope & Radiation Recent Development
Table 102. Ciaeriar Company Information
Table 103. Ciaeriar Introduction and Business Overview
Table 104. Ciaeriar Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Ciaeriar Nuclear Radiopharmaceutical Product Offerings
Table 106. Ciaeriar Recent Development
Table 107. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
Table 108. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Introduction and Business Overview
Table 109. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product Offerings
Table 111. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Nuclear Radiopharmaceutical Downstream Customers
Table 115. Nuclear Radiopharmaceutical Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Radiopharmaceutical Product Picture
Figure 2. Global Nuclear Radiopharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Nuclear Radiopharmaceutical Sales Volume (2019-2030) & (Units)
Figure 5. Global Nuclear Radiopharmaceutical Sales Price (2019-2030) & (US$/Unit)
Figure 6. Nuclear Radiopharmaceutical Report Years Considered
Figure 7. Global Nuclear Radiopharmaceutical Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Nuclear Radiopharmaceutical Players Sales Volume Ranking (2023) & (Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Radiopharmaceutical Revenue in 2023
Figure 10. Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Diagnostic Picture
Figure 12. Therapeutic Picture
Figure 13. Global Nuclear Radiopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Nuclear Radiopharmaceutical Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Nuclear Radiopharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
Figure 16. Global Nuclear Radiopharmaceutical Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Nuclear Radiopharmaceutical Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Oncology
Figure 19. Product Picture of Thyroid
Figure 20. Product Picture of Cardiology
Figure 21. Product Picture of Others
Figure 22. Global Nuclear Radiopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Nuclear Radiopharmaceutical Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Nuclear Radiopharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
Figure 25. Global Nuclear Radiopharmaceutical Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Nuclear Radiopharmaceutical Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Nuclear Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Nuclear Radiopharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Nuclear Radiopharmaceutical Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Nuclear Radiopharmaceutical Sales Volume (%), (2019-2030)
Figure 39. United States Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 45. China Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 47. China Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 57. India Nuclear Radiopharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Nuclear Radiopharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 59. India Nuclear Radiopharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 60. Nuclear Radiopharmaceutical Industrial Chain
Figure 61. Nuclear Radiopharmaceutical Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Nuclear Radiopharmaceutical market?
The top companies in the global Nuclear Radiopharmaceutical market are Nihon Medi-Physics Co.,Ltd.、Curium Pharma、Cardinal Health.
Related Reports
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 7116 million in 2025 and is projected to reach US$ 11560 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 114
USD 3950.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2026
The global Nuclear Radiopharmaceutical market was valued at US$ 7116 million in 2025 and is anticipated to reach US$ 11560 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 126
USD 2900.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Radiopharmaceutical market is projected to grow from US$ 6678 million in 2024 to US$ 10850 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 167
USD 4900.00
(Single User License)
Global Nuclear Radiopharmaceutical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Radiopharmaceutical market size was US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 96
USD 4250.00
(Single User License)
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 113
USD 3950.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2025
The global market for Nuclear Radiopharmaceutical was valued at US$ 6678 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
Global and United States Nuclear Radiopharmaceutical Market Report & Forecast 2024-2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published Date: 2024-09-13
Pages: 136
USD 4350.00
(Single User License)
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published Date: 2024-09-13
Pages: 127
USD 3950.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Insights, Forecast to 2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published Date: 2024-09-13
Pages: 146
USD 4900.00
(Single User License)
Global Nuclear Radiopharmaceutical Market Research Report 2024
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published Date: 2024-09-13
Pages: 88
USD 2900.00
(Single User License)
Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 7116 million in 2025 and is projected to reach US$ 11560 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-02-11
Pages: 114
USD 3950.00 (Single User License)Global Nuclear Radiopharmaceutical Market Research Report 2026
The global Nuclear Radiopharmaceutical market was valued at US$ 7116 million in 2025 and is anticipated to reach US$ 11560 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-02-11
Pages: 126
USD 2900.00 (Single User License)Global Nuclear Radiopharmaceutical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Radiopharmaceutical market is projected to grow from US$ 6678 million in 2024 to US$ 10850 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 167
USD 4900.00 (Single User License)Global Nuclear Radiopharmaceutical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Radiopharmaceutical market size was US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 96
USD 4250.00 (Single User License)Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Radiopharmaceutical was estimated to be worth US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 113
USD 3950.00 (Single User License)Global Nuclear Radiopharmaceutical Market Research Report 2025
The global market for Nuclear Radiopharmaceutical was valued at US$ 6678 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-02-14
Pages: 94
USD 2900.00 (Single User License)Global and United States Nuclear Radiopharmaceutical Market Report & Forecast 2024-2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published: 2024-09-13
Pages: 136
USD 4350.00 (Single User License)Nuclear Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published: 2024-09-13
Pages: 127
USD 3950.00 (Single User License)Global Nuclear Radiopharmaceutical Market Insights, Forecast to 2030
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published: 2024-09-13
Pages: 146
USD 4900.00 (Single User License)Global Nuclear Radiopharmaceutical Market Research Report 2024
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Published: 2024-09-13
Pages: 88
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now